Evidence mapPaperPMID 40958508Full record

ArticleJournal of clinical research in pediatric endocrinology2026

Type 1 Diabetes Mellitus and Transfer from Pediatric to Adult Care: A Single-Center Experience

Betul Yigit Yalcin, Ummahan Tercan, Melek Yildiz, Hulya Hacisahinogullari, Gulsah Yenidunya Yalin, Nurdan Gul, Ozlem Soyluk Selcukbiricik, Ayse Kubat Uzum, Sukran Poyrazoglu, Firdevs Bas and 3 more

Abstract read
In one paragraph

Article in Journal of clinical research in pediatric endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Betul Yigit Yalcinİstanbul University, İstanbul Faculty of Medicine, Department of Endocrinology, İstanbul, TürkiyeORCID 0000-0002-5533-330X
Ummahan Tercanİstanbul University, İstanbul Faculty of Medicine, Department of Pediatrics, Division of Paediatrics Endocrinology, İstanbul, TürkiyeORCID 0000-0002-3240-3408
Melek Yildizİstanbul University, İstanbul Faculty of Medicine, Department of Pediatrics, Division of Paediatrics Endocrinology, İstanbul, TürkiyeORCID 0000-0002-6603-2983
Hulya Hacisahinogullariİstanbul University, İstanbul Faculty of Medicine, Department of Endocrinology, İstanbul, TürkiyeORCID 0000-0001-9989-6473
Gulsah Yenidunya Yalinİstanbul University, İstanbul Faculty of Medicine, Department of Endocrinology, İstanbul, TürkiyeORCID 0000-0002-9013-5237
Nurdan Gulİstanbul University, İstanbul Faculty of Medicine, Department of Endocrinology, İstanbul, TürkiyeORCID 0000-0002-1187-944X
Ozlem Soyluk Selcukbiricikİstanbul University, İstanbul Faculty of Medicine, Department of Endocrinology, İstanbul, TürkiyeORCID 0000-0003-0732-4764
Ayse Kubat Uzumİstanbul University, İstanbul Faculty of Medicine, Department of Endocrinology, İstanbul, TürkiyeORCID 0000-0003-0478-1193
Sukran Poyrazogluİstanbul University, İstanbul Faculty of Medicine, Department of Pediatrics, Division of Paediatrics Endocrinology, İstanbul, TürkiyeORCID 0000-0001-6806-9678
Firdevs Basİstanbul University, İstanbul Faculty of Medicine, Department of Pediatrics, Division of Paediatrics Endocrinology, İstanbul, TürkiyeORCID 0000-0001-9689-4464
Kubilay Karsidagİstanbul University, İstanbul Faculty of Medicine, Department of Endocrinology, İstanbul, TürkiyeORCID 0000-0002-9332-1262
Ilhan Satmanİstanbul University, İstanbul Faculty of Medicine, Department of Endocrinology, İstanbul, TürkiyeORCID 0000-0001-8613-1797
Feyza Darendelilerİstanbul University, İstanbul Faculty of Medicine, Department of Pediatrics, Division of Paediatrics Endocrinology, İstanbul, TürkiyeORCID 0000-0003-4786-0780

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Type 1 diabetes mellitus (T1DM) requires lifelong follow-up, and the transition from pediatric to adult care may influence clinical outcomes. To evaluate sociodemographic, clinical, and laboratory characteristics associated with the transition process in patients with T1DM and to compare two different transition models. Methods: Patients with T1DM transferred to an adult outpatient clinic between 2001 and 2022 were retrospectively assessed. Demographic data, metabolic parameters, complications, and treatment modalities before and after transition were assessed. Transition was performed either as a single-session model (Model 1) or as a gradual process over 4-6 months (Model 2). Results: A total of 64 patients transitioned over the 21 year study period. The annual number of follow-up visits was significantly lower in adult care (3.0±0.9 vs. 2.1±1.8 visits/year; p=0.009). HbA1c levels were also lower in adulthood (8.9% vs. 8.3%; p=0.007). Total insulin dose was lower (0.95 vs. 0.75 IU/kg/day; p=0.009), whereas the basal insulin ratio was higher (43.1% vs. 52.8%; p<0.0001). Although mean body mass index slightly decreased, obesity prevalence increased. No significant differences were observed between the two transition models in terms of glycemic outcomes, insulin requirements, or complication rates. Conclusion: A structured transition process was associated with improved glycemic control and treatment adaptation in T1DM, regardless of whether it is implemented as a single-session or gradual model. The absence of major differences between models may support the importance of individualized, patient-centered transition strategies.

Indexed as

Diabetes Mellitus, Type 1Transition to Adult CareAdolescentAdultBlood GlucoseChildFemaleFollow-Up StudiesGlycated HemoglobinHumansInsulinMaleRetrospective StudiesYoung AdultBlood GlucoseGlycated HemoglobinInsulindiabetes caretransitionType 1 diabetes mellitus

Identifiers

PMID40958508
PMCPMC13325666

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.